mergers and acquisition
Gilead to Pay Nearly $12B for CAR T-Cell Company
Gilead to Pay Nearly $12B for CAR T-Cell Company
Jef Akst | Aug 28, 2017
The massive sum will buy out Kite Pharma, whose cancer therapy is expected to be among the first of its type approved by the FDA.
Thermo Fisher to Buy Patheon for $5.2 Billion
Thermo Fisher to Buy Patheon for $5.2 Billion
Aggie Mika | May 16, 2017
The scientific supply giant seeks to expand into biopharma development and manufacturing.  
Monsanto and Bayer Announce Approval of Massive Merger
Monsanto and Bayer Announce Approval of Massive Merger
Bob Grant | Dec 13, 2016
On Tuesday, shareholders at the agribusiness giant approved the $66 billion deal with the European pharmaceutical firm.
Novartis Buys US Drugmaker for Up To $665 Million
Novartis Buys US Drugmaker for Up To $665 Million
Tracy Vence | Nov 23, 2016
The Swiss pharma giant is acquiring Oklahoma-based Selexys Pharmaceuticals, a maker of drugs for inflammatory and thrombotic diseases.
Allergan’s Buying Spree Rolls On
Allergan’s Buying Spree Rolls On
Bob Grant | Sep 21, 2016
The Ireland-based pharma company makes a $1.7 billion offer to acquire Tobira Therapeutics, a US firm developing liver disease drugs.
Allergan Set to Buy Vitae
Allergan Set to Buy Vitae
Bob Grant | Sep 16, 2016
The Irish drugmaker has made a $639 million dollar offer to buy the US-based biopharma.
Bayer Looks to Buy Monsanto
Bayer Looks to Buy Monsanto
Bob Grant | Sep 14, 2016
The US agribusiness behemoth agreed to a $57 billion buyout offer from the European pharmaceutical giant.
Pfizer to Buy Medivation for $14 Billion
Pfizer to Buy Medivation for $14 Billion
Bob Grant | Aug 22, 2016
The pharma giant is purchasing the San Francisco–based cancer drugmaker to boost its oncology portfolio.
TS Picks: June 6, 2016
TS Picks: June 6, 2016
Jef Akst | Jun 6, 2016
American Society of Clinical Oncology meeting edition 
$1.5 Billion Pharma Buyout for Leukemia Drug
$1.5 Billion Pharma Buyout for Leukemia Drug
Jef Akst | Jun 1, 2016
Jazz Pharmaceuticals is set to purchase Celator to acquire an experimental treatment for acute myeloid leukemia.